1.Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes.
Yan LI ; Kai SUN ; Meng-Yao AN ; Ying-Ying PAN ; Tao SUN ; Yong-Qiang YIN ; Yi KANG ; Jian-Shi LOU
Chinese Journal of Applied Physiology 2018;34(2):106-110
		                        		
		                        			OBJECTIVES:
		                        			To investigate the effect of taurine magnesium coordination compound (TMCC) on torsades de pointes (TdP) in isolated guinea pig hearts.
		                        		
		                        			METHODS:
		                        			Healthy male guinea pigs weighting 250~300 g were randomly divided into 4 groups:①TdP model group (=7):Isolated hearts were perfused by normal K-H solution 20 minutes, then perfused by slowly activated delayed rectifier potassium current(IKs) blocker 10mol/L Chromanol 293B under hypokalemic solution(1.8 mmol/L) to establish TdP model;②~④ TdP model + TMCC group (=6):Isolated hearts were perfused by normal K-H solution for 20 minutes, then perfused by IKs blocker 10mol/L Chromanol 293B under hypokalemic solution(1.8 mmol/L) for 60 minutes, at the same time TMCC which concentration was 1, 2, 4 mmol/L was administered respectively by Langendorff retrograde aortic perfusion method. Cardiac surface electrocardiogram of guinea pigs was collected and recorded by Biopac electrophysiological recorder. Incidence of TdP, transmural dispersion of repolarization (TDR), instability of QT interval were acquired from Lead Ⅱ electrocardiograph (ECG) wave forms to describe the effect of TMCC on TdP model. Datas were acquired at the time of 20 min and pre-TdP, in case there was no TdP observed, a value of 60 min was entered for calculation purpose.
		                        		
		                        			RESULTS:
		                        			Incidence of TdP in TdP model group was 6/7. TdP incidence could be decreased significantly by 1, 2, 4 mmol/L TMCC, and was 5/6, 1/6, 0/6 respectively. Compared with the pre-drug, Chromanol 293B under hypokalemic solution in TdP model group increased TDR(corrected) evidently(<0.01). Compared with the pre-drug, 1, 2, 4 mmol/L TMCC in TdP model + TMCC group could decrease the increased TDR(corrected) induced by Chromanol 293B under hypokalemic solution(>0.05). Compared with the TdP model group, 2, 4 mmol/L TMCC could evidently decrease the instability of QT interval induced by Chromanol 293B under hypokalemic solution(<0.05). During the establishment of TdP model, P waves in more than one cardiac cycle continuously were disappeared in ECG. However, P wave could always be seen independent in ECG acquired from TdP model + TMCC group.
		                        		
		                        			CONCLUSIONS
		                        			TMCC can play the role against TdP through decreasing TDR and instability of QT interval, and inhibiting early after depolarization(EAD).
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Anti-Arrhythmia Agents
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Electrocardiography
		                        			;
		                        		
		                        			Guinea Pigs
		                        			;
		                        		
		                        			In Vitro Techniques
		                        			;
		                        		
		                        			Long QT Syndrome
		                        			;
		                        		
		                        			Magnesium
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Random Allocation
		                        			;
		                        		
		                        			Taurine
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Torsades de Pointes
		                        			;
		                        		
		                        			drug therapy
		                        			
		                        		
		                        	
2.GABA Receptor Activity Suppresses the Transition from Inter-ictal to Ictal Epileptiform Discharges in Juvenile Mouse Hippocampus.
Yan-Yan CHANG ; Xin-Wei GONG ; Hai-Qing GONG ; Pei-Ji LIANG ; Pu-Ming ZHANG ; Qin-Chi LU
Neuroscience Bulletin 2018;34(6):1007-1016
		                        		
		                        			
		                        			Exploring the transition from inter-ictal to ictal epileptiform discharges (IDs) and how GABA receptor-mediated action affects the onset of IDs will enrich our understanding of epileptogenesis and epilepsy treatment. We used Mg-free artificial cerebrospinal fluid (ACSF) to induce epileptiform discharges in juvenile mouse hippocampal slices and used a micro-electrode array to record the discharges. After the slices were exposed to Mg-free ACSF for 10 min-20 min, synchronous recurrent seizure-like events were recorded across the slices, and each event evolved from inter-ictal epileptiform discharges (IIDs) to pre-ictal epileptiform discharges (PIDs), and then to IDs. During the transition from IIDs to PIDs, the duration of discharges increased and the inter-discharge interval decreased. After adding 3 μmol/L of the GABA receptor agonist muscimol, PIDs and IDs disappeared, and IIDs remained. Further, the application of 10 μmol/L muscimol abolished all the epileptiform discharges. When the GABA receptor antagonist bicuculline was applied at 10 μmol/L, IIDs and PIDs disappeared, and IDs remained at decreased intervals. These results indicated that there are dynamic changes in the hippocampal network preceding the onset of IDs, and GABA receptor activity suppresses the transition from IIDs to IDs in juvenile mouse hippocampus.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Animals, Newborn
		                        			;
		                        		
		                        			Bicuculline
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Epilepsy
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			GABA-A Receptor Agonists
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			GABA-A Receptor Antagonists
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Hippocampus
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			In Vitro Techniques
		                        			;
		                        		
		                        			Magnesium
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Membrane Potentials
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred C57BL
		                        			;
		                        		
		                        			Muscimol
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Nerve Net
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Receptors, GABA-A
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
3.Effect of Magnesium Sulfate, Nifedipine Tablet Combined Salvia Injection on ET-1/NO, TXA2/PGI2 and Hemorheology of Preeclampsia Patients.
Xiao-ying ZHENG ; Jing YAO ; Jia-mei ZHU ; Mei LI ; Shu-qiong QIU ; Zhao-xia ZHU ; Ming ZHANG
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(8):962-965
OBJECTIVETo observe the effect of magnesium sulfate, Nifedipine Tablet (NT) combined Salvia Injection (SI) on endothelin-1 (ET-1), nitric oxide (NO), thromboxane A2(TXA2), prostacyclin I2(PG2), and hemorheology of preeclampsia patients.
METHODSTotally 704 preeclampsia patients were randomly assigned to the treatment group and the control group, 352 cases in each group. All patients were treated with magnesium sulfate combined NT (on the first day: slow intravenous injection of magnesium sulfate 5 g + intravenous dripping of magnesium sulfate injection 10 g + oral administration of NT 30 mg; on the second and third day, intravenous dripping of magnesium sulfate injection 10 g + oral administration of NT 30 mg), while those in the treatment group were dripped with SI additionally at 20 mL per day for 3 consecutive days. Before and after treatment plasma levels of endothelin-1 (ET-1), nitric oxide (NO), TXA2, PGi2, and hemorheology indicators [such as high blood viscosity (HBV), low blood viscosity (LBV), plasma viscosity (PV), erythrocyte rigidity index (ERI), fibrinogen (FIB)] of two groups were detected.
RESULTSCompared with the same group before treatment, serum levels of ET-1, TXA2, HBV, LBV, PV, ERI, and FIB decreased in the two groups after treatment (P <0. 05), but levels of NO and PG2 increased (P <0. 05). Compared with the control group in the same period, levels of ET-1, TXA2, HBV, LBV, PV, ERI, and FIB decreased in the treatment group after treatment (P <0. 05), but levels of NO and PGI2 increased (P <0. 05).
CONCLUSIONMagnesium sulfate, NT combined SI could effectively regulate the balance of ET-1/NO and TXA2/PGI2, and improve hemorheology of preeclampsia patients.
Drug Therapy, Combination ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Endothelin-1 ; metabolism ; Epoprostenol ; metabolism ; Female ; Hemorheology ; Humans ; Injections ; Magnesium Sulfate ; administration & dosage ; pharmacology ; therapeutic use ; Nifedipine ; administration & dosage ; pharmacology ; therapeutic use ; Nitric Oxide ; metabolism ; Pre-Eclampsia ; drug therapy ; Pregnancy ; Salvia ; Tablets ; Thromboxane A2 ; metabolism
4.Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats.
Kyubok JIN ; Tae Hee KIM ; Yeong Hoon KIM ; Yang Wook KIM
The Korean Journal of Internal Medicine 2013;28(2):197-205
		                        		
		                        			
		                        			BACKGROUND/AIMS: Magnesium (Mg) is an essential element for vascular function and blood pressure regulation. Several studies have demonstrated that Mg concentration is inversely associated with blood pressure, and that Mg supplementation attenuates hypertension. The purpose of this study was to evaluate the effect of dietary Mg supplementation on the blood pressure effects of an angiotensin II receptor blocker (ARB) in hypomagnesemic rats. METHODS: Fifty male Sprague-Dawley rats were randomly divided into Mg-deficient (n = 30), normal diet plus Mg (n = 10), and control groups (n = 10). Mg-free, high-Mg, and normal-Mg diets were respectively fed to the rats. After 14 weeks, 10 of the 30 Mg-deficient rats were treated with Mg, 10 Mg-deficient rats received an ARB, and 10 Mg-deficient rats received an ARB plus Mg for 4 weeks. RESULTS: Systolic blood pressure was significantly higher in the Mg-deficient rats than in the control rats at week 14. Hypomagnesemic rats exhibited decreased systolic blood pressure after treatment with Mg, and systolic blood pressure showed a greater decrease after ARB treatment. Treatment with the ARB/Mg combination resulted in the greatest decrease in systolic blood pressure. Mg deficiency did not affect the serum angiotensin II level, but did increase the serum aldosterone concentration. Concomitant Mg/ARB supplementation significantly decreased the elevated serum aldosterone level in hypomagnesemic rats. Kidney tissues of the hypomagnesemic rats revealed mild to moderate inflammatory infiltrates. Mg and/or ARB treatment did not reverse the inflammatory reaction in the kidneys of hypomagnesemic rats. CONCLUSIONS: Concurrent dietary Mg supplementation can enhance ARB-induced blood pressure reduction in rats with hypomagnesemic hypertension.
		                        		
		                        		
		                        		
		                        			Aldosterone/blood
		                        			;
		                        		
		                        			Angiotensin II/blood
		                        			;
		                        		
		                        			Angiotensin II Type 1 Receptor Blockers/*pharmacology
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antihypertensive Agents/*pharmacology
		                        			;
		                        		
		                        			Biological Markers/blood
		                        			;
		                        		
		                        			Blood Pressure/*drug effects
		                        			;
		                        		
		                        			*Dietary Supplements
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Hypertension/blood/*drug therapy/pathology/physiopathology
		                        			;
		                        		
		                        			Kidney/drug effects/pathology
		                        			;
		                        		
		                        			Magnesium/blood/*pharmacology
		                        			;
		                        		
		                        			Magnesium Deficiency/blood/*drug therapy/pathology/physiopathology
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Rats, Sprague-Dawley
		                        			;
		                        		
		                        			Systole
		                        			;
		                        		
		                        			Time Factors
		                        			
		                        		
		                        	
5.Apical acidity decreases inhibitory effect of omeprazole on Mg2+ absorption and claudin-7 and -12 expression in Caco-2 monolayers.
Narongrit THONGON ; Nateetip KRISHNAMRA
Experimental & Molecular Medicine 2012;44(11):684-693
		                        		
		                        			
		                        			Clinical studies reported hypomagnesaemia in long-term omeprazole usage that was probably due to intestinal Mg2+ wasting. Our previous report demonstrated the inhibitory effect of omeprazole on passive Mg2+ transport across Caco-2 monolayers. The present study aimed to identify the underlying mechanism of omeprazole suppression of passive Mg2+ absorption. By using Caco-2 monolayers, we demonstrated a potent inhibitory effect of omeprazole on passive Mg2+, but not Ca2+, transport across Caco-2 monolayers. Omeprazole shifted the %maximum passive Mg2+ transport-Mg2+ concentration curves to the right, and increased the half maximal effective concentration of those dose-response curves, indicating a lower Mg2+ affinity of the paracellular channel. By continually monitoring the apical pH, we showed that omeprazole suppressed apical acid accumulation. Neomycin and spermine had no effect on passive Mg2+ transport of either control or omeprazole treated monolayers, indicating that omeprazole suppressed passive Mg2+ transport in a calcium sensing receptor (CaSR)-independent manner. The results of western blot analysis showed that omeprazole significantly suppressed claudin (Cldn)-7 and -12, but not Cldn-2, expression in Caco-2 cells. By using apical solution of pH 5.5, 6.0, 6.5, and 7.0, we found that apical acidity markedly increased passive Mg2+ transport, Mg2+ affinity of the paracellular channel, and Cldn-7 and -12 expression in Caco-2 monolayers. Apical acidity abolished the inhibitory effect of omeprazole on passive Mg2+ transport and Cldn-7 and -12 expression. Our results provided the evidence for the regulation of intestinal passive Mg2+ absorption by luminal acidity-induced increase in Cldn-7 and -12 expression.
		                        		
		                        		
		                        		
		                        			Absorption/drug effects
		                        			;
		                        		
		                        			Caco-2 Cells
		                        			;
		                        		
		                        			Calcium/metabolism
		                        			;
		                        		
		                        			Claudins/genetics/*metabolism
		                        			;
		                        		
		                        			Dose-Response Relationship, Drug
		                        			;
		                        		
		                        			Gene Expression/drug effects
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hydrogen-Ion Concentration
		                        			;
		                        		
		                        			Magnesium/*metabolism
		                        			;
		                        		
		                        			Omeprazole/*pharmacology
		                        			;
		                        		
		                        			Proton Pump Inhibitors/*pharmacology
		                        			;
		                        		
		                        			Receptors, Calcium-Sensing/metabolism
		                        			
		                        		
		                        	
6.The effect of the magnesium supplementation on vascular calcification in rats.
Ji-Xia PEN ; Li LI ; Xiong WANG ; Ya-Hui ZHANG ; Xue-Feng LI ; Sheng-Ying WU
Chinese Journal of Applied Physiology 2012;28(1):20-23
OBJECTIVETo observe the role of magnesium sulfate in vascular calcification, to explore the role and the mechanism of magnesium sulfate in vascular calcification.
METHODSThe vascular calcification model was established by administration of vitamin D3 plus nicotine (VDN) in SD rats. To estimate the extent of calcification by Von Kossa staining, calcium content and alkaline phosphatase activity, osteopontin (OPN) mRNA were determined by using semi-quantitative reverse-transcription polymerase chain reaction.The malondialdehyde (MDA) and nitric oxide (NO) content and activities of superoxide dismutase(SOD) were measured by biochemistry.
RESULTSA strong positive staining of black/brown areas among the elastic fibers of the medial layer in calcified aorta by Von Kossa staining, calcium content and ALP activity in calcified arteries increased by 3.9-and 3.4-fold as compared with the controls. The expression of OPN mRNA was up-regulated by 40% (P < 0.01). The lipid peroxidation products MDA in vascular were increased 2.0-fold (P < 0.01). The NO content and SOD activity were greatly decreased by 64% and 72% (P < 0.01), respectively, compared with controls. However, calcium content and ALP activity in VDN plus magnesium sulfate group were lower than those in VDN group. Low and high dosage magnesium sulfate obviously relieved degree of calcification in the cardiovascular tissues in a dosage-dependent manner (P < 0.01).
CONCLUSIONMagnesium sulfate plays a role in the pathogenesis of vascular calcification by reducing vascular calcification and decreasing vascular injury.
Animals ; Cholecalciferol ; adverse effects ; Magnesium ; pharmacology ; Male ; Nicotine ; adverse effects ; Osteopontin ; metabolism ; RNA, Messenger ; genetics ; Rats ; Vascular Calcification ; chemically induced ; pathology
7.Mg(2+) inhibits ATP-activated current mediated by rat P2X4 receptors expressed in Xenopus oocytes.
Fang PENG ; Yu-Qin ZHANG ; Yan ZENG ; Yan-Ling ZHOU
Acta Physiologica Sinica 2012;64(1):75-81
		                        		
		                        			
		                        			To investigate the modulation of Mg(2+) on rat P2X4 receptors and its underlying mechanism, we transcribed cDNA coding for wild-type and mutant P2X4 receptors to cRNA in vitro, injected the cRNA to oocytes of Xenopus laevis using the microinjection technique and revealed the effect of Mg(2+) on ATP-activated currents (I(ATP)) mediated by P2X4 receptors using the two-electrode whole-cell voltage clamp technique. The effects of extracellular Mg(2+) on I(ATP) were as follows: (1) In oocytes expressing P2X4 receptors, Mg(2+) with concentration ranging from 0.5-10 mmol/L inhibited the amplitude of I(ATP) in a concentration-dependent and reversible manner, with a 50% inhibitory concentration value (IC(50)) of (1.24 ± 0.07) mmol/L for current activated by 100 μmol/L ATP. (2) Mg(2+) (1 mmol/L) shifted the dose-response curve for I(ATP) right-downward without changing the EC(50), but reduced the maximal current (E(max)) by (42.0 ± 2.1)%. (3) After being preincubated with Mg(2+) for 80 s, the inhibitory effect of the Mg(2+) on I(ATP) reached the maximum. (4) The inhibition of Mg(2+) on I(ATP) was independent of membrane potential from -120 mV to +60 mV. (5) Compared with the current activated by 100 μmol/L ATP in the wild-type P2X4 receptors, mutant P2X4 D280Q responded to the application of 100 μmol/L ATP with a smaller current. The peak current was only (4.12 ± 0.15)% of that seen in wild-type receptors. Mutant P2X4 D280E responded to ATP stimulation with a current similar to that observed in cells expressing wild-type receptors. (6) When Asp280 was removed from P2X4, the current amplitude of I(ATP) was increased almost one-fold, and Mg(2+) with concentration ranging from 0.5-10 mmol/L did not affect the I(ATP) significantly. The results suggest that Mg(2+) inhibits I(ATP) mediated by P2X4 receptors non-competitively, reversibly, concentration-dependently, time-dependently and voltage-independently. The inhibitory effect of Mg(2+) might be realized by acting on the site Asp280 of the P2X4 receptors.
		                        		
		                        		
		                        		
		                        			Adenosine Triphosphate
		                        			;
		                        		
		                        			antagonists & inhibitors
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Magnesium
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Membrane Potentials
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Oocytes
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Patch-Clamp Techniques
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Receptors, Purinergic P2X4
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Xenopus laevis
		                        			
		                        		
		                        	
8.hNUDT16: a universal decapping enzyme for small nucleolar RNA and cytoplasmic mRNA.
Guangwen LU ; Jie ZHANG ; Yan LI ; Zhixin LI ; Na ZHANG ; Xiang XU ; Tingting WANG ; Zhenhong GUAN ; George F GAO ; Jinghua YAN
Protein & Cell 2011;2(1):64-73
		                        		
		                        			
		                        			Human NUDT16 (hNUDT16) is a decapping enzyme initially identified as the human homolog to the Xenopus laevis X29. As a metalloenzyme, hNUDT16 relies on divalent cations for its cap-hydrolysis activity to remove m⁷GDP and m²²⁷GDP from RNAs. Metal also determines substrate specificity of the enzyme. So far, only U8 small nucleolar RNA (snoRNA) has been identified as the substrate of hNUDT16 in the presence of Mg²(+). Here we demonstrate that besides U8, hNUDT16 can also actively cleave the m⁷GDP cap from mRNAs in the presence of Mg²(+) or Mn²(+). We further show that hNUDT16 does not preferentially recognize U8 or mRNA substrates by our cross-inhibition and quantitative decapping assays. In addition, our mutagenesis analysis identifies several key residues involved in hydrolysis and confirms the key role of the REXXEE motif in catalysis. Finally an investigation into the subcellular localization of hNUDT16 revealed its abundance in both cytoplasm and nucleus. These findings extend the substrate spectrum of hNUDT16 beyond snoRNAs to also include mRNA, demonstrating the pleiotropic decapping activity of hNUDT16.
		                        		
		                        		
		                        		
		                        			Amino Acid Motifs
		                        			;
		                        		
		                        			Biocatalysis
		                        			;
		                        		
		                        			Cell Nucleus
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			Consensus Sequence
		                        			;
		                        		
		                        			Cytoplasm
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Guanosine Diphosphate
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Histidine
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hydrolysis
		                        			;
		                        		
		                        			Luciferases
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Magnesium
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Manganese
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Mutagenesis
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Pyrophosphatases
		                        			;
		                        		
		                        			antagonists & inhibitors
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			RNA Caps
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			RNA, Small Nucleolar
		                        			;
		                        		
		                        			chemistry
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pharmacology
		                        			
		                        		
		                        	
9.Effects of different neutralizing agents on succinate production by Actinobacillus succinogenes NJ113.
Zhuona YANG ; Min JIANG ; Jian LI ; Xiaojiang FANG ; Guizi YE ; Xuefei BAI ; Xiaoyu ZHENG ; Ping WEI
Chinese Journal of Biotechnology 2010;26(11):1500-1506
		                        		
		                        			
		                        			Different neutralizing agents were used as pH controller to investigate their effects on the growth and succinic acid production of Actinobacillus succinogenes NJ113. The fermentation results showed that Ca(OH)2, CaCO3 and NH4OH were not suitable for succinic acid production by A. succinogenes NJ113 because of their negative effects on cell growth. When Na-base was used, cells would flocculate and lump, and due to the sodium ion concentration reaching to a high level, OD660 dropped sharply after 12 h of fermentation. Mg-base was better because there was no significant inhibition by magnesium ion. Two combined neutralizing agents were used to maintain pH level, one with NaOH and Mg(OH)2 while the other with Na2CO3 and Mg(OH)2. The optimum ratios of the combined neutralizing agents were both 1:1 (g:g) when using 100 g/L glucose. When NaOH and Mg(OH)2 were chosen with the ratio of 1:1(g:g), 69.8 g/L of the succinic acid and 74.5% of the yield was obtained.
		                        		
		                        		
		                        		
		                        			Actinobacillus
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Fermentation
		                        			;
		                        		
		                        			Hydrogen-Ion Concentration
		                        			;
		                        		
		                        			Industrial Microbiology
		                        			;
		                        		
		                        			Magnesium Hydroxide
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Sodium Hydroxide
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Succinic Acid
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
10.Stabilizers of horseradish peroxidase.
Xinhuan MAO ; Xiang LI ; Shanshan WANG ; Wenjing ZHANG ; Chengming ZENG
Chinese Journal of Biotechnology 2009;25(3):388-391
		                        		
		                        			
		                        			Keeping an enzyme in its native form with high catalytic activity is of great significance. In the present study, thermal stabilizers of horseradish peroxidase (HRP) were screened. The results indicated that thermal stability of HRP was enhanced by magnesium sulphate and gelatin. A synergic effect of magnesium sulphate and gelatin was observed. In the presence of the stabilizer, the enzymatic activity of HRP remained 89% after kept for 80 h at 50 degrees C and 57% for 90 days at room temperature. Thermal alterations of HRP structure in the absence and presence of the stabilizers were explored by using UV absorption spectra at 402 nm (Soret band), intrinsic fluorescence and 8-anilinonaphthalene-1-sulfonic acid (ANS) fluorescence. The results suggested that magnesium sulphate and gelatin attenuated the extent of unfolding of HRP and therefore the native enzyme structure was stabilized.
		                        		
		                        		
		                        		
		                        			Drug Synergism
		                        			;
		                        		
		                        			Enzyme Stability
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Gelatin
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Horseradish Peroxidase
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Hot Temperature
		                        			;
		                        		
		                        			Magnesium Sulfate
		                        			;
		                        		
		                        			pharmacology
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail